Condition: Aortic Valve Stenosis · Sponsor: HemoCept Inc.
The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
This description comes directly from the study's public registry record.
Katharine Adkins · 303-442-2395 · kathari.adkins@bch.org
Always discuss trial participation with your own doctor first.
| Boulder Heart | Boulder, Colorado, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07205341